Job Title: Special Counsel
Gillian M. Fenton, Esq., CLP has been a member of LES (USA & Canada) since 1992, and served as the society President in 2020-2021. She is presently a member of the society Public Policy Committee.
Gillian is also Special Counsel for Innovation and Government Collaborations at GSK Vaccines. Her practice includes a wide variety of business development transactions, R&D collaborations and nondilutive funding agreements with U.S. Government entities (NIH/NIAID, BARDA and DARPA), all in support of the vaccines pipeline. Prior to joining GSK, Gillian was VP, Associate General Counsel & Chief Intellectual Property Counsel at Emergent BioSolutions Inc., where she founded the IP department and supported all IP aspects of the company’s IPO and subsequent 9 years of growth through M&A in the vaccines, biodefense, and global health fields.
Education: J.D. cum laude, Suffolk University Law School; B.Sc. Biochemistry, Trinity College.
Admissions: MA, MD, DC. Registered U.S. Patent Attorney.